Cancers, Free Full-Text

Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Join a FREE Breast Cancer Survivorship Program

CA: A Cancer Journal for Clinicians - Wiley Online Library

Cancers, Free Full-Text

Harboring Hard and Soft Cells Lets Tumors Grow and Metastasize Simultaneously

8 Ways to prevent cancer & be healthy -Siteman Cancer Center

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes, Breast Cancer Research

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Remission, cancer-free, no evidence of disease: What's the difference?

Cancers, Free Full-Text

I Am Cancer Free! - Cancer Free Gift - Pin

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Free PSD Breast cancer awareness editable text effect